GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioInfra Life Science Inc (XKRX:266470) » Definitions » Other Income (Expense)

BioInfra Life Science (XKRX:266470) Other Income (Expense) : ₩-714.2 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is BioInfra Life Science Other Income (Expense)?

BioInfra Life Science's other income expense for the BioInfra Life Science's pretax income for the six months ended in Dec. 2024 was ₩-714.2 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-714.2 Mil.


BioInfra Life Science Other Income (Expense) Historical Data

The historical data trend for BioInfra Life Science's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioInfra Life Science Other Income (Expense) Chart

BioInfra Life Science Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only 99.89 2,137.56 569.42 88.06 -714.19

BioInfra Life Science Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only 99.89 2,137.56 569.42 88.06 -714.19

BioInfra Life Science Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-714.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioInfra Life Science  (XKRX:266470) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


BioInfra Life Science Business Description

Traded in Other Exchanges
N/A
Address
Daehak-ro 49, 7th Floor, Jongno-gu, Seoul, KOR, 03127
BioInfra Life Science Inc is a bio-technology company engaged in developing cancer gene treatments and technologies that systematically monitor the possibility of metastasis and recurrence in blood for cancer patients.

BioInfra Life Science Headlines

No Headlines